Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 37 | 23 | 23 | 23 | 22 |
| Accounts receivable | 182 | -174 | -134 | -178 | -40 |
| Other Working Capital | 574 | -1,846 | -6,176 | 90 | 710 |
| Other Operating Activity | -2,954 | -2,059 | -2,152 | -1,514 | -1,230 |
| Operating Cash Flow | $-2,160 | $-4,055 | $-8,438 | $-1,579 | $-538 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -102 | -8 | -5 | -9 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 58 | -58 |
| Investing Cash Flow | $-102 | $-8 | $-5 | $49 | $-58 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 0 | 2,312 | N/A |
| Common Stock Issued | 41 | 1,627 | 14,234 | 0 | 0 |
| Other Financing Activity | 382 | 0 | -724 | -296 | 9,757 |
| Financing Cash Flow | $423 | $1,627 | $13,510 | $2,016 | $9,757 |
| Beginning Cash Position | 14,295 | 16,732 | 11,665 | 11,179 | 2,018 |
| End Cash Position | 12,455 | 14,295 | 16,732 | 11,665 | 11,179 |
| Net Cash Flow | $-1,840 | $-2,436 | $5,067 | $486 | $9,161 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,160 | -4,055 | -8,438 | -1,579 | -538 |
| Capital Expenditure | -102 | -8 | -5 | N/A | N/A |
| Free Cash Flow | -2,262 | -4,063 | -8,443 | -1,579 | -538 |